Senate Committee Votes to Authorize Military Strikes on Syria
On a 10-7 vote, the Senate Foreign Relations Committee approved a measure Wednesday that would grant the president up to 90 days to wage war on Syria without the use of ground troops.
On a 10-7 vote, the Senate Foreign Relations Committee approved a measure Wednesday that would grant the president up to 90 days to wage war on Syria without the use of ground troops.
The full Senate will have to approve the resolution before it means anything, but the political divisions on the committee foreshadow a bumpy road for passage. Democrats and Republicans voted for and against the authorization, with Sen. John McCain, R.-Ariz., installing language that would make it “the policy of the United States to change the momentum on the battlefield in Syria.” Sen. Ed Markey, a Massachusetts liberal who took over Secretary of State John Kerry’s seat, voted present.
With military action, even the use of missile strikes, strongly opposed by the polled public, it’s anyone’s guess as to whether Congress ultimately approves military action.
— Posted by Peter Z. Scheer
Rock Solid JournalismIn 2026, amid chaos and the nonstop flurry of headlines, Truthdig remains independent, fact-based and focused on exposing what power tries to hide.
Support Independent Journalism.
Editorial Cartoons
Education
Luckily for patrons, there appears to be little support for the cuts in Congress.
Editorial Cartoons
Economic Justice
Millions of Americans who have ACA health plans are facing soaring premiums in 2026, without help from the enhanced subsidies that Congress failed to renew.
Politics
As a congressman, Sean Duffy made an impassioned legal case against executive overreach. A decade later, judges have used those arguments to rebuke him for withholding billions in transportation funding.
Economic Justice
Nearly 60% of enrollees say they are unable to cover the costs of a $300 increase in their premiums. Another 20% can’t afford a $1,000 increase.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.